People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...

Varshavski: I asked a bunch of different specialists what's the one medical breakthrough they're excited about in their ...

Systemic medications, particularly selective beta blockers and calcium channel blockers, can significantly influence intraocular pressure (IOP) over time, according to study results published in ...

HUNTINGTON — GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza and Wegovy started as a way to treat diabetes but have since become popular tools for weight loss. Dr. Matthew Christiansen ...

That is perhaps why there has been so much buzz surrounding the class of drug known as a GLP-1 agonist.

Adam Gilden, MD, MSCE, is an associate director of the Obesity Medicine Fellowship at University of Colorado School of Medicine and associate director of the Colorado University Medicine Weight ...

While the disorders are uncommon, "use of these medications is dramatically ... conflicting findings about possible links between GLP-1 receptor agonists and NAION. "It is estimated that by ...

GLP-1RA use may raise the risk of hypotension and syncope. According to Dr Al-Aly’s team, careful monitoring of blood pressure and adjustment of antihypertensive medications may be needed. GLP-1 RA ...

Opens in a new tab or window Few medications have had such a meteoric rise as semaglutide (Ozempic, Wegovy) and tirzepatide (Zepbound), the GLP-1-based ... system," use them briefly, change ...

Just this month, for instance, a study of VA data suggested that GLP-1 use is associated with a reduced ... titled The Ozempic Revolution, intended to change that. The book is billed as a ...

Authors say large, multisite study should provide reassurance for short-term risk. (HealthDay News) — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased ...